MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-HP-10-0000841
Horizon Bioceuticals Pvt Ltd
Horizon Bioceuticals Pvt Ltd - pharma in Panipat, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹110.37 Cr
▼ 9% YoY
Net profit · FY 2025
₹5.46 Cr
Net margin 4.9%
EBITDA · FY 2025
₹11.21 Cr
EBITDA margin 10.2%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.73 Cr
Issued & subscribed
Open charges
₹42.05 Cr
Satisfied ₹14.95 Cr
Company age
28 yrs
Est. 1998
Employees · EPFO
43
Provident fund records
About Horizon Bioceuticals Pvt Ltd
Data last updated:
Horizon Bioceuticals Pvt Ltd is a private limited company based in Panipat, Haryana, India, a subsidiary of Curewell Drugs And Pharmaceuticals Pvt. Ltd.. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 October 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24232HR1998PTC034053. Its GSTIN is 06AABCH3880M1ZB (Haryana). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.73 Cr. It is led by directors including Manoj Garg and Ashok Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 240 Sector – 29 HUDA, Panipat, Haryana, India – 132103.
As per the financials filed for FY 2025, the company reported a revenue of ₹110.37 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹5.46 Cr (net margin 4.9%) and EBITDA of ₹11.21 Cr (EBITDA margin 10.2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 6% over five years.
The company has about 43 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹42.05 Cr and satisfied charges of ₹14.95 Cr on record. Court records list 80 cases involving the company, including 58 filed by the company and 22 filed against it; 13 cases are pending. The company has 6 deals on record (5 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.84 Cr; the latest was in March 2014. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Unicure Remedies Private Limited with revenue of ₹112.25 Cr.
Horizon Bioceuticals Pvt Ltd is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-10-0000841). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232HR1998PTC034053
Registration Number 034053
Incorporation Date 16 October 1998
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Curewell Drugs And Pharmaceuticals Pvt. Ltd.
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HP-10-0000841
Recognitions & Rankings of Horizon Bioceuticals
Contact details
Horizon Bioceuticals Pvt Ltd's registered office is in Panipat, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 240 Sector – 29 HUDA, Panipat, Haryana, India – 132103
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Horizon Bioceuticals Pvt Ltd, buy the company report.
Comprehensive company report
Horizon Bioceuticals Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activities of Horizon Bioceuticals are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Horizon Bioceuticals Pvt Ltd, buy the company report.
Financials of Horizon Bioceuticals Pvt Ltd
FY 2025 filings availableHorizon Bioceuticals Pvt Ltd reported revenue of ₹110.37 Cr (down 9% YoY) for FY 2025.
Revenue · FY 2025
₹110.37 Cr ▼ 9%
Net profit · FY 2025
₹5.46 Cr margin 4.9%
EBITDA · FY 2025
₹11.21 Cr margin 10.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 9%
3 years · compounded
▼ 2%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 7%
5 years · compounded
▲ 12%
Revenue fell 9% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.21 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.46 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.2% | ||||
| Net Profit Margin | 4.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Horizon Bioceuticals Pvt Ltd, buy the company report.
Board of directors of Horizon Bioceuticals Pvt Ltd
Horizon Bioceuticals has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Garg Also directs: Yug Dyers & Processors Private Limited, Curewell Limited, Curewell Biotech Limited and 5 more | Director | 10 Mar 2005 | 21 Years 7 Months | Current |
| Ashok Kumar Also directs: Yug Dyers & Processors Private Limited, Curewell Limited, Curewell Biotech Limited and 5 more | Director | 16 Oct 1998 | 28 Years 0 Months | Current |
| Mamta Also directs: Curewell Limited, Curewell Biotech Limited, Varav Biogenesis Private Limited and 1 more | Director | 16 Oct 1998 | 28 Years 0 Months | Current |
| Surinder Sharma Also directs: Curewell Limited, Varav Biogenesis Private Limited | Director | 22 Aug 2014 | 12 Years 2 Months | Current |
| Charanjit Kumar Also directs: Curewell Limited, Curewell Biotech Limited, Abble Biological Private Limited and 4 more | Director | 10 Mar 2005 | 21 Years 7 Months | Current |
Peer comparison
Horizon Bioceuticals Pvt Ltd is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Unicure Remedies Private Limited | ₹112.25 Cr (FY 2025) | -13.0% | Vadodara, Gujarat, India | |||
| Apple Formulations Private Limited. | ₹111.56 Cr (FY 2025) | 3.0% | Delhi, India | |||
| Penang Enterprises Private Limited | ₹111.42 Cr (FY 2025) | 21.0% | Mumbai, Maharashtra, India | |||
| Horizon Bioceuticals Pvt Ltdthis company | ₹110.37 Cr (FY 2025) | ₹5.46 Cr | 4.9% | -9.0% | 43 | Panipat, Haryana, India |
| Inventaa Industries Private Limited | ₹109.72 Cr (FY 2025) | -17.0% | Kanchikacherla, Andhra Pradesh, India | |||
| Chemtech Intermediates Limited | ₹109 Cr (FY 2025) | 33.0% | Vadodara, Gujarat, India | |||
| Quest Laboratories Limited | ₹108.21 Cr (FY 2025) | 31.0% | Dhar, Madhya Pradesh, India |
To see the full peer comparison of Horizon Bioceuticals Pvt Ltd, buy the company report.
Auditor
Horizon Bioceuticals Pvt Ltd is audited by Vinod Grover And Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vinod Grover And Associates | FY 2024 | 0013331N |
Shareholding
The shareholding of Horizon Bioceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Horizon Bioceuticals Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
₹42.05 Cr
Satisfied charges
₹14.95 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 May 2025 | 101134334 | Others | ₹1.3 Cr | Open | |
| 03 Nov 2023 | 100811751 | Others | ₹8.9 Cr | Open | |
| 24 Aug 2023 | 100775291 | Others | ₹6.5 Cr | Open | |
| 23 May 2022 | 100576052 | Axis Bank Limited | ₹1.6 Cr | Open | |
| 14 Sep 2020 | 100372391 | Axis Bank Limited | ₹1.44 Cr | Open |
To see the full charge records of Horizon Bioceuticals Pvt Ltd, buy the company report.
Total charge records: 21 View all charges
Deals & funding
Horizon Bioceuticals Pvt Ltd has 6 deals on record (5 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.84 Cr; the latest was in March 2014.
Total deals
6
Funding rounds
5
Secondary share transfer
1
Disclosed funding
₹1.84 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2014 | Funding round | ₹11.9 Lakh | Investors: Varav Tradex Private Limited , an individual |
| Oct 2011 | Funding round | ₹27 Lakh | Investors: Cure Well Drugs & Pharmaceuticals Private Limited, Yug Dyers & Processors Private Limited |
| May 2010 | Secondary share transfer | Undisclosed | Buyer: Varav Tradex Private Limited Seller: 3 individuals |
| Mar 2009 | Funding round | ₹10 Lakh | Investors: 3 individuals |
| Sep 2008 | Funding round | ₹68 Lakh | Investors: Cure Well Drugs & Pharmaceuticals Private Limited |
To see the full deal history of Horizon Bioceuticals Pvt Ltd, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Horizon Bioceuticals Pvt Ltd has 80 court cases on record: 58 filed by Horizon Bioceuticals, 22 filed against it. 13 cases are pending and 67 are disposed.
Total cases
80
Filed by the company
58
Filed against the company
22
Pending
13
Disposed
67
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 59 | 15 | 9 |
| District courts | 19 | 5 | 4 |
| Supreme Court | 2 | 2 | 0 |
Cases on record (5 of 80)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Dr. Reddys Laboratories Limited | Pending |
| Bombay High Court | Court case (LPETN) | Filed against the company by Procter and Gamble Health Limited | Pending |
| Bombay High Court | Arbitration matter | Filed against the company by Procter and Gamble Health Limited | Disposed |
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed against the company by Glaxosmithkline Pharmaceuticals Limited | Disposed |
| High Court of Delhi | Court case (C.A.(COMM.IPD-TM)) | Filed against the company by Glaxosmithkline Pharmaceuticals Limited | Disposed |
To see the full case history of Horizon Bioceuticals Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Horizon Bioceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Horizon Bioceuticals Pvt Ltd has a workforce of 43 employees on its EPFO records as of Sep 24, 2025, across 2 active EPFO establishments.
Employee count
43
Active EPFO establishments
2
Employee growth
-6.52%
GST
Horizon Bioceuticals has 4 GST registrations: 2 active and 2 cancelled or inactive.
Total GSTINs
4
Active
2
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AABCH3880M1ZB | Haryana | Active | 01 Jul 2017 |
| 02AABCH3880M2ZI | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Horizon Bioceuticals Pvt Ltd, buy the company report.
Recent activity
Horizon Bioceuticals Pvt Ltd has 6 board changes on record since 1998: 5 appointments and 1 cessation. The latest: Surinder Sharma ceased to be Additional Director on 23 Sep 2014.
AGM
Horizon Bioceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 1.30 Cr with Charge ID 101134334 was registered on 19 May 2025.
Filing
Horizon Bioceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Charges
A charge with Others amounted to Rs. 8.90 Cr with Charge ID 100811751 was registered on 03 Nov 2023.
Charges
A charge with Axis Bank Limited of Rs. 22.25 Cr registered on 08 Mar 2018 with Charge ID 100172890 was modified on 11 Sep 2023.
Charges
A charge with Others amounted to Rs. 6.50 Cr with Charge ID 100775291 was registered on 24 Aug 2023.
Charges
A charge registered on 30 Apr 2010 via Charge ID 10219155 with Director Of Indsutries Of Himachal Pradesh Through District Industries Centre H P was fully satisfied on 12 Jan 2023.
Charges
A charge registered on 05 Mar 2012 via Charge ID 10342486 with Punjab National Bank was fully satisfied on 09 Jan 2023.
Charges
A charge registered on 25 Mar 2011 via Charge ID 10277317 with Punjab National Bank was fully satisfied on 09 Jan 2023.
Charges
A charge registered on 30 Aug 2018 via Charge ID 100212135 with Axis Bank Limited was fully satisfied on 07 Jan 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.60 Cr with Charge ID 100576052 was registered on 23 May 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.44 Cr with Charge ID 100372391 was registered on 14 Sep 2020.
36 earlier events are in the company report.
Frequently asked questions
Horizon Bioceuticals is an active private limited company based in Panipat, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 October 1998 (28+ years old) and is registered under CIN U24232HR1998PTC034053.
Horizon Bioceuticals has 5 current directors:
- Manoj Garg - Director
- Ashok Kumar - Director
- Mamta - Director
- Surinder Sharma - Director
- Charanjit Kumar - Director
The latest financial statements of Horizon Bioceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Horizon Bioceuticals is 06AABCH3880M1ZB, registered in Haryana. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 02AABCH3880M2ZI (Himachal Pradesh).
The CIN (Corporate Identification Number) of Horizon Bioceuticals is U24232HR1998PTC034053. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Horizon Bioceuticals has 80 court cases on record: 58 filed by the company and 22 filed against it. 13 are pending. Most are in the high courts.
Horizon Bioceuticals was incorporated on 16 October 1998, making it 28+ years old. It is registered with the Registrar of Companies, Haryana.
Horizon Bioceuticals has 6 deals on record (5 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.84 Cr; the latest was in March 2014.
The peers of Horizon Bioceuticals by revenue are Unicure Remedies Private Limited, Apple Formulations Private Limited, Penang Enterprises Private Limited, Inventaa Industries Private Limited, Chemtech Intermediates Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Surinder Sharma ceased to be Additional Director on 23 Sep 2014. Surinder Sharma was appointed as Director on 22 Aug 2014. Charanjit Kumar was appointed as Director on 10 Mar 2005. Horizon Bioceuticals has 6 board changes on record in total.
Yes, Horizon Bioceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-10-0000841).